Yolanda Mira

1.1k total citations
42 papers, 761 citations indexed

About

Yolanda Mira is a scholar working on Hematology, Internal Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Yolanda Mira has authored 42 papers receiving a total of 761 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Hematology, 22 papers in Internal Medicine and 12 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Yolanda Mira's work include Blood Coagulation and Thrombosis Mechanisms (24 papers), Venous Thromboembolism Diagnosis and Management (22 papers) and Atrial Fibrillation Management and Outcomes (8 papers). Yolanda Mira is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (24 papers), Venous Thromboembolism Diagnosis and Management (22 papers) and Atrial Fibrillation Management and Outcomes (8 papers). Yolanda Mira collaborates with scholars based in Spain, Netherlands and Slovakia. Yolanda Mira's co-authors include Amparo Vayá, Fernando Ferrando, Justo Aznar, Amparo Estellés, Francisco España, Piedad Villa, Dolores Corella, Paola Villa, Cristina Falcó and A. Estellés and has published in prestigious journals such as SHILAP Revista de lepidopterología, Arteriosclerosis Thrombosis and Vascular Biology and British Journal of Haematology.

In The Last Decade

Yolanda Mira

39 papers receiving 727 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yolanda Mira Spain 16 482 388 210 116 97 42 761
Fernando Ferrando Spain 17 458 1.0× 351 0.9× 223 1.1× 73 0.6× 99 1.0× 35 737
H. Vielhaber Germany 14 605 1.3× 295 0.8× 199 0.9× 124 1.1× 53 0.5× 25 734
Francesca Duca Italy 7 528 1.1× 336 0.9× 176 0.8× 101 0.9× 58 0.6× 9 799
Elisabetta Sacchi Italy 11 812 1.7× 431 1.1× 175 0.8× 139 1.2× 226 2.3× 25 1.2k
Shogo Takano Japan 6 387 0.8× 268 0.7× 163 0.8× 83 0.7× 70 0.7× 13 703
S I A M Islam United Kingdom 7 751 1.6× 483 1.2× 293 1.4× 92 0.8× 128 1.3× 7 866
Jan‐Leendert P. Brouwer Netherlands 8 396 0.8× 358 0.9× 195 0.9× 102 0.9× 100 1.0× 11 710
Johan R. Meinardi Netherlands 11 470 1.0× 304 0.8× 191 0.9× 189 1.6× 114 1.2× 18 835
A.W. Broekmans Netherlands 14 788 1.6× 336 0.9× 189 0.9× 181 1.6× 189 1.9× 28 944
Min Ki ten Kate Netherlands 8 372 0.8× 328 0.8× 186 0.9× 82 0.7× 108 1.1× 10 668

Countries citing papers authored by Yolanda Mira

Since Specialization
Citations

This map shows the geographic impact of Yolanda Mira's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yolanda Mira with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yolanda Mira more than expected).

Fields of papers citing papers by Yolanda Mira

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yolanda Mira. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yolanda Mira. The network helps show where Yolanda Mira may publish in the future.

Co-authorship network of co-authors of Yolanda Mira

This figure shows the co-authorship network connecting the top 25 collaborators of Yolanda Mira. A scholar is included among the top collaborators of Yolanda Mira based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yolanda Mira. Yolanda Mira is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ferrando, Fernando & Yolanda Mira. (2015). Effective and Safe Management of Oral Anticoagulation Therapy in Patients Who Use the Internet-Accessed Telecontrol Tool SintromacWeb. SHILAP Revista de lepidopterología. 4(2). e10–e10. 8 indexed citations
2.
3.
Navarro, Silvia, Pilar Medina, Yolanda Mira, et al.. (2008). Haplotypes of the EPCR gene, prothrombin levels, and the risk of venous thrombosis in carriers of the prothrombin G20210A mutation. Haematologica. 93(6). 885–891. 43 indexed citations
4.
Falcó, Cristina, María Simó, Fernando Ferrando, et al.. (2007). Influence of lipids and obesity on haemorheological parameters in patients with deep vein thrombosis. Thrombosis and Haemostasis. 98(9). 621–626. 18 indexed citations
5.
Medina, Pilar, Silvia Navarro, Amparo Estellés, et al.. (2004). Contribution of polymorphisms in the endothelial protein C receptor gene to soluble endothelial protein C receptor and circulating activated protein C levels, and thrombotic risk. Thrombosis and Haemostasis. 91(5). 905–911. 83 indexed citations
6.
Mira, Yolanda, Amparo Vayá, Dolores Corella, et al.. (2004). Factor V Leiden and prothrombin G20210A mutations in young adults with cryptogenic ischemic stroke. Thrombosis and Haemostasis. 91(5). 1031–1034. 59 indexed citations
7.
Mira, Yolanda, José Mateo, Cristina Falcó, et al.. (2003). Prothrombin G20210A mutation and oral contraceptive use increase upper-extremity deep vein thrombotic risk. Thrombosis and Haemostasis. 89(3). 452–457. 43 indexed citations
8.
Vayá, Amparo, Yolanda Mira, Fernando Ferrando, et al.. (2002). Hyperlipidaemia and venous thromboembolism in patients lacking thrombophilic risk factors. British Journal of Haematology. 118(1). 255–259. 75 indexed citations
9.
Estellés, A., et al.. (2000). Factor V Leiden in absence of activated protein C resistance after orthotopic liver transplantation in a patient without thrombosis but with familial thrombophilia.. PubMed. 85(1). 111–2. 6 indexed citations
10.
Estellés, Amparo, Yolanda Mira, Francisco España, et al.. (2000). PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects. British Journal of Haematology. 111(1). 122–128. 83 indexed citations
11.
Vayá, Amparo, et al.. (2000). High and low molecular weight heparins do not modify red blood cell aggregability in vitro.. PubMed. 23(1). 67–70. 3 indexed citations
12.
Aznar, José A., Amparo Vayá, A. Estellés, et al.. (2000). Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.. PubMed. 85(12). 1271–6. 60 indexed citations
13.
Villa, Piedad, Fernando Ferrando, Hortensia Faus, et al.. (2000). Quantification of D-dimer using a new fully automated assay: its application for the diagnosis of deep vein thrombosis.. PubMed. 85(5). 520–4. 15 indexed citations
14.
España, Francisco, Paola Villa, Yolanda Mira, et al.. (1999). Factor V Leiden and antibodies against phospholipids and protein S in a young woman with recurrent thromboses and abortion.. PubMed. 84(1). 80–4. 13 indexed citations
15.
Mira, Yolanda, et al.. (1998). Hemorheological alterations and hypercoagulable state in deep vein thrombosis.. PubMed. 19(4). 265–70. 8 indexed citations
16.
Vayá, Amparo, Luís Larrea, F Gomis, Yolanda Mira, & Francisco Javier Aznar. (1995). Cerebral venous sinus thrombosis associated with refractory anaemia with excess of blasts.. PubMed. 37(3). 201–3. 1 indexed citations
17.
Villa, Piedad, et al.. (1995). Inherited Homozygous Resistance to Activated Protein C. Thrombosis and Haemostasis. 74(2). 794–795. 1 indexed citations
18.
Mira, Yolanda, et al.. (1992). [Hemostasis screening in the emergency laboratory].. PubMed. 37(3). 161–4. 1 indexed citations
19.
Vayá, Amparo, et al.. (1989). [Evaluation of erythrocyte deformability in carriers of thalassemic trait with the Hanss' hemorheometer].. PubMed. 34(1). 50–2. 1 indexed citations
20.
Baiget, M., et al.. (1983). Spanish Delta-Beta<sub>-</sub>Thalassemia: Hematological Studies and Composition of the Gamma-Chains in Ten Homozygous Patients. Acta Haematologica. 70(5). 341–344. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fernando Ferrando Breakdown of academic impact, for papers by H. Vielhaber Breakdown of academic impact, for papers by Francesca Duca Breakdown of academic impact, for papers by Elisabetta Sacchi Breakdown of academic impact, for papers by Shogo Takano Breakdown of academic impact, for papers by S I A M Islam Breakdown of academic impact, for papers by Jan‐Leendert P. Brouwer Breakdown of academic impact, for papers by Johan R. Meinardi Breakdown of academic impact, for papers by A.W. Broekmans Breakdown of academic impact, for papers by Min Ki ten Kate
Rankless by CCL
2026